Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 1
1(25.0%)
4Total
N/A(3)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05499663Phase 1Completed

Title: Leveraging Technology to Address Health Outcomes of Cancer Survivors

Role: collaborator

NCT07223879Not ApplicableNot Yet Recruiting

Trial of Novel, On-Demand Virtual Reality to Amplify Practice Efficacy (NO VAPE) Added to Cognitive Behavioral Therapy for Nicotine Vaping Cessation

Role: lead

NCT06861907Completed

IMPRINT VR Trainer Evaluation

Role: lead

NCT04667689Not ApplicableCompleted

An Online Cognitive Assessment in Cancer Patients

Role: collaborator

NCT02132793Not ApplicableCompleted

Remote Exercise for Learning Anger and Excitation Management

Role: collaborator

All 5 trials loaded